Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that its President and CEO, Dr. Michael R. Bristow, will present at the Rodman & Renshaw Annual Global Investment Conference, taking place September 9-10, 2013 at the Millennium Broadway Hotel in New York City. ARCA’s presentation will take place Tuesday, September 10, 2013 at 10:25am ET
Hey, check out all the research scientist jobs. Post your resume today!
